Skip to main content

Deoxycholic acid


Basic information
Metabolite name

Deoxycholic acid

HMDB0000626
C04483
222528
Synonyms

deoxycholate

No. of studies

22

 

Relationship between Deoxycholic acid and depression (count: 22)
Study Study Type Comparison groups Tissue Organism Up/Down regulated
Study M061 Type1 depressed group vs. control group Plasma Human Down
Study M101 Type1 CSD group vs. control group Faece C57BL/6 mouse Down
Study M1022 Type1 CUS group vs. control group Faece C57BL/6 mouse Up
Study M1022 Type2 CUS + middle dose of Tongxieyaofang neutral polysaccharide group vs. CUS group Faece C57BL/6 mouse Down
Study M1022 Type2 CUS + high dose of Tongxieyaofang neutral polysaccharide group vs. CUS group Faece C57BL/6 mouse Down
Study M1022 Type2 CUS + low dose of Tongxieyaofang neutral polysaccharide group vs. CUS group Faece C57BL/6 mouse Down
Study M1022 Type2 CUS + fructooligosaccharide + galactooligosaccharides group vs. CUS group Faece C57BL/6 mouse Down
Study M1022 Type2 CUS + Tongxieyaofang neutral polysaccharide + Tongxieyaofang acidic polysaccharide group vs. CUS group Faece C57BL/6 mouse Down
Study M1053 Type1 CUMS group vs. control group Liver Sprague-Dawley rat Up
Study M1053 Type2 CUMS + quercetin group vs. CUMS group Liver Sprague-Dawley rat Down
Study M1072 Type1 CUMS group vs. control group Intestine Cynomolgus monkey Up
Study M1072 Type1 CUMS group vs. control group Faece Cynomolgus monkey Up
Study M1086 Type1 CUMS group vs. control group Faece C57BL/6 mouse Down
Study M117 Type1 CVS group vs. control group Faece Wistar rat Up
Study M541 Type1 CUMS group vs. control group Serum Sprague-Dawley rat Up
Study M541 Type2 CUMS + high dose of AS group vs. CUMS group Serum Sprague-Dawley rat Down
Study M541 Type2 CUMS + low dose of AS group vs. CUMS group Serum Sprague-Dawley rat Down
Study M541 Type2 CUMS + venlafaxine group vs. CUMS group Serum Sprague-Dawley rat Down
Study M582 Type1 CUMS group vs. control group Faece C57BL/6N mouse Down
Study M582 Type2 CUMS + fluoxetine group vs. CUMS group Faece C57BL/6N mouse Up
Study M604 Type1 CUMS group vs. control group Faece Sprague-Dawley rat Down
Study M608 Type1 CUMS group vs. control group Faece Sprague-Dawley rat Down
Study M677 Type1 CVS group vs. control group Faece Wistar rat Up
Study M677 Type2 CVS + Chaihu-Shu-Gan-San group vs. CVS group Faece Wistar rat Down
Study M677 Type2 CVS + fluoxetine group vs. CVS group Faece Wistar rat Down
Study M691 Type1 CUMS group vs. control group Plasma Sprague-Dawley rat Down
Study M691 Type2 CUMS + low dose of Chaihu-Baishao group vs. CUMS group Plasma Sprague-Dawley rat Up
Study M691 Type2 CUMS + low dose of Chaihu group vs. CUMS group Plasma Sprague-Dawley rat Up
Study M774 Type1 MDD group vs. control group Serum Human Down
Study M815 Type1 CUMS group vs. control group Serum Sprague-Dawley rat Up
Study M815 Type2 CUMS + high dose of Radix Bupleuri–Radix Paeoniae Alba group vs. CUMS group Serum Sprague-Dawley rat Down
Study M902 Type1 sleep deprivation group vs. control group Faece Wistar rat Up
Study M902 Type2 sleep deprivation + fish oil group vs. sleep deprivation group Faece Wistar rat Down
Study M907 Type1 MDD group vs. control group Plasma Human Down
Study M912 Type1 CUMS group vs. control group Faece ICR mouse Up
Study M912 Type1 CUMS group vs. control group Serum ICR mouse Up
Study M912 Type1 CUMS group vs. control group Liver ICR mouse Up
Study M928 Type1 CUMS group vs. control group Faece C57BL/6 mouse Down
Study M936 Type1 CUMS group vs. control group Faece Sprague-Dawley rat Up
Study M947 Type1 CUMS group vs. control group Plasma Sprague-Dawley rat Up
Study M953 Type1 CRS group vs. control group Faece Sprague-Dawley rat Up